TMSP: Notification of Drug Re-registration Approval from Subsidiary

TMSP announced that its subsidiary Huangshan TMSP Co., Ltd. and Huangshan TMSP Mint Pharmaceutical Co., Ltd. have received the "Drug Re-registration Approval Notice" issued by the Anhui Provincial Drug Administration. The approved drugs include Kidney Strengthening Tablets, Andrographis Paniculata Capsules, Cold Relief Tablets, Cold and Fever Granules, Lion's Mane Mushroom Tablets, Muscle and Bone Grass Tablets, Antelope Detox Tablets, Antelope Cold Tablets, Brain Nourishing Tablets, Mulberry and Chrysanthemum Cold Tablets, Polygonum Multiflorum Longevity Tablets, and Blood Nourishing and Calming Tablets. The approval notices for these drugs are valid until 2030 and are applicable for symptoms such as lower back pain, weakness in the legs, dizziness, and tinnitus. This move will have a positive impact on the company's subsequent production, sales, and promotion